Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1998 Mar 15;330(Pt 3):1123–1128. doi: 10.1042/bj3301123

Efficient CD28 signalling leads to increases in the kinase activities of the TEC family tyrosine kinase EMT/ITK/TSK and the SRC family tyrosine kinase LCK.

S Gibson 1, K Truitt 1, Y Lu 1, R Lapushin 1, H Khan 1, J B Imboden 1, G B Mills 1
PMCID: PMC1219252  PMID: 9494076

Abstract

Optimal T cell activation requires crosslinking of the T cell receptor (TCR) concurrently with an accessory receptor, most efficiently CD28. Crosslinking of CD28 leads to increased interleukin 2 (IL2) production, inhibition of anergy and prevention of programmed cell death. Crosslinking of CD28 leads to rapid increases in tyrosine phosphorylation of specific intracellular substrates including CD28 itself. Since CD28 does not encode an intrinsic tyrosine kinase domain, CD28 must activate an intracellular tyrosine kinase(s). Indeed, crosslinking of CD28 increases the activity of the intracellular tyrosine kinases EMT/ITK and LCK. The phosphatidylinositol 3-kinase (PI3K) and GRB2 binding site in CD28 is dispensable for optimal IL2 production in Jurkat T cells. We demonstrate herein that murine Y170 (equivalent to human Y173) in CD28 is also dispensable for activation of the SRC family tyrosine kinase LCK and the TEC family tyrosine kinase EMT/ITK. In contrast, the distal three tyrosines in CD28 are required for optimal IL2 production as well as for optimal activation of the LCK and EMT/ITK tyrosine kinases. The distal three tyrosines of CD28, however, are not required for recruitment of PI3K to CD28. Furthermore, PI3K is recruited to CD28 in JCaM1 cells which lack LCK and in which EMT/ITK is not activated by ligation of CD28. Thus optimal activation of LCK or EMT/ITK is not obligatory for recruitment of PI3K to CD28 and thus is also not required for tyrosine phosphorylation of the YMNM motif in CD28. Taken together the data indicate that the distal three tyrosines in CD28 are integral to the activation of LCK and EMT/ITK and for subsequent IL2 production.

Full Text

The Full Text of this article is available as a PDF (253.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. August A., Dupont B. Activation of src family kinase lck following CD28 crosslinking in the Jurkat leukemic cell line. Biochem Biophys Res Commun. 1994 Mar 30;199(3):1466–1473. doi: 10.1006/bbrc.1994.1396. [DOI] [PubMed] [Google Scholar]
  2. August A., Dupont B. CD28 of T lymphocytes associates with phosphatidylinositol 3-kinase. Int Immunol. 1994 May;6(5):769–774. doi: 10.1093/intimm/6.5.769. [DOI] [PubMed] [Google Scholar]
  3. August A., Gibson S., Kawakami Y., Kawakami T., Mills G. B., Dupont B. CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line. Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9347–9351. doi: 10.1073/pnas.91.20.9347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cai Y. C., Cefai D., Schneider H., Raab M., Nabavi N., Rudd C. E. Selective CD28pYMNM mutations implicate phosphatidylinositol 3-kinase in CD86-CD28-mediated costimulation. Immunity. 1995 Oct;3(4):417–426. doi: 10.1016/1074-7613(95)90171-x. [DOI] [PubMed] [Google Scholar]
  5. Crooks M. E., Littman D. R., Carter R. H., Fearon D. T., Weiss A., Stein P. H. CD28-mediated costimulation in the absence of phosphatidylinositol 3-kinase association and activation. Mol Cell Biol. 1995 Dec;15(12):6820–6828. doi: 10.1128/mcb.15.12.6820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ellis J. H., Burden M. N., Vinogradov D. V., Linge C., Crowe J. S. Interactions of CD80 and CD86 with CD28 and CTLA4. J Immunol. 1996 Apr 15;156(8):2700–2709. [PubMed] [Google Scholar]
  7. Finck B. K., Linsley P. S., Wofsy D. Treatment of murine lupus with CTLA4Ig. Science. 1994 Aug 26;265(5176):1225–1227. doi: 10.1126/science.7520604. [DOI] [PubMed] [Google Scholar]
  8. Freeman G. J., Gribben J. G., Boussiotis V. A., Ng J. W., Restivo V. A., Jr, Lombard L. A., Gray G. S., Nadler L. M. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science. 1993 Nov 5;262(5135):909–911. doi: 10.1126/science.7694363. [DOI] [PubMed] [Google Scholar]
  9. Gibson S., August A., Branch D., Dupont B., Mills G. M. Functional LCK Is required for optimal CD28-mediated activation of the TEC family tyrosine kinase EMT/ITK. J Biol Chem. 1996 Mar 22;271(12):7079–7083. doi: 10.1074/jbc.271.12.7079. [DOI] [PubMed] [Google Scholar]
  10. Gibson S., August A., Kawakami Y., Kawakami T., Dupont B., Mills G. B. The EMT/ITK/TSK (EMT) tyrosine kinase is activated during TCR signaling: LCK is required for optimal activation of EMT. J Immunol. 1996 Apr 15;156(8):2716–2722. [PubMed] [Google Scholar]
  11. Gibson S., Leung B., Squire J. A., Hill M., Arima N., Goss P., Hogg D., Mills G. B. Identification, cloning, and characterization of a novel human T-cell-specific tyrosine kinase located at the hematopoietin complex on chromosome 5q. Blood. 1993 Sep 1;82(5):1561–1572. [PubMed] [Google Scholar]
  12. Gross J. A., St John T., Allison J. P. The murine homologue of the T lymphocyte antigen CD28. Molecular cloning and cell surface expression. J Immunol. 1990 Apr 15;144(8):3201–3210. [PubMed] [Google Scholar]
  13. Heyeck S. D., Berg L. J. Developmental regulation of a murine T-cell-specific tyrosine kinase gene, Tsk. Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):669–673. doi: 10.1073/pnas.90.2.669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Heyeck S. D., Wilcox H. M., Bunnell S. C., Berg L. J. Lck phosphorylates the activation loop tyrosine of the Itk kinase domain and activates Itk kinase activity. J Biol Chem. 1997 Oct 3;272(40):25401–25408. doi: 10.1074/jbc.272.40.25401. [DOI] [PubMed] [Google Scholar]
  15. Janeway C. A., Jr, Bottomly K. Signals and signs for lymphocyte responses. Cell. 1994 Jan 28;76(2):275–285. doi: 10.1016/0092-8674(94)90335-2. [DOI] [PubMed] [Google Scholar]
  16. June C. H., Bluestone J. A., Nadler L. M., Thompson C. B. The B7 and CD28 receptor families. Immunol Today. 1994 Jul;15(7):321–331. doi: 10.1016/0167-5699(94)90080-9. [DOI] [PubMed] [Google Scholar]
  17. King P. D., Sadra A., Teng J. M., Xiao-Rong L., Han A., Selvakumar A., August A., Dupont B. Analysis of CD28 cytoplasmic tail tyrosine residues as regulators and substrates for the protein tyrosine kinases, EMT and LCK. J Immunol. 1997 Jan 15;158(2):580–590. [PubMed] [Google Scholar]
  18. Lenschow D. J., Zeng Y., Thistlethwaite J. R., Montag A., Brady W., Gibson M. G., Linsley P. S., Bluestone J. A. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science. 1992 Aug 7;257(5071):789–792. doi: 10.1126/science.1323143. [DOI] [PubMed] [Google Scholar]
  19. Liao X. C., Fournier S., Killeen N., Weiss A., Allison J. P., Littman D. R. Itk negatively regulates induction of T cell proliferation by CD28 costimulation. J Exp Med. 1997 Jul 21;186(2):221–228. doi: 10.1084/jem.186.2.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Liao X. C., Littman D. R. Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk. Immunity. 1995 Dec;3(6):757–769. doi: 10.1016/1074-7613(95)90065-9. [DOI] [PubMed] [Google Scholar]
  21. Lu Y., Granelli-Piperno A., Bjorndahl J. M., Phillips C. A., Trevillyan J. M. CD28-induced T cell activation. Evidence for a protein-tyrosine kinase signal transduction pathway. J Immunol. 1992 Jul 1;149(1):24–29. [PubMed] [Google Scholar]
  22. Lu Y., Phillips C. A., Bjorndahl J. M., Trevillyan J. M. CD28 signal transduction: tyrosine phosphorylation and receptor association of phosphoinositide-3 kinase correlate with Ca(2+)-independent costimulatory activity. Eur J Immunol. 1994 Nov;24(11):2732–2739. doi: 10.1002/eji.1830241124. [DOI] [PubMed] [Google Scholar]
  23. Lu Y., Phillips C. A., Trevillyan J. M. Phosphatidylinositol 3-kinase activity is not essential for CD28 costimulatory activity in Jurkat T cells: studies with a selective inhibitor, wortmannin. Eur J Immunol. 1995 Feb;25(2):533–537. doi: 10.1002/eji.1830250234. [DOI] [PubMed] [Google Scholar]
  24. Lucas P. J., Negishi I., Nakayama K., Fields L. E., Loh D. Y. Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. J Immunol. 1995 Jun 1;154(11):5757–5768. [PubMed] [Google Scholar]
  25. Mills G. B., Arima N., May C., Hill M., Schmandt R., Li J., Miyamoto N. G., Greene W. C. Neither the LCK nor the FYN kinases are obligatory for IL-2-mediated signal transduction in HTLV-I-infected human T cells. Int Immunol. 1992 Nov;4(11):1233–1243. doi: 10.1093/intimm/4.11.1233. [DOI] [PubMed] [Google Scholar]
  26. Pagès F., Ragueneau M., Rottapel R., Truneh A., Nunes J., Imbert J., Olive D. Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling. Nature. 1994 May 26;369(6478):327–329. doi: 10.1038/369327a0. [DOI] [PubMed] [Google Scholar]
  27. Pike L. J., Eakes A. T., Krebs E. G. Characterization of affinity-purified insulin receptor/kinase. Effects of dithiothreitol on receptor/kinase function. J Biol Chem. 1986 Mar 15;261(8):3782–3789. [PubMed] [Google Scholar]
  28. Prasad K. V., Cai Y. C., Raab M., Duckworth B., Cantley L., Shoelson S. E., Rudd C. E. T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif. Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2834–2838. doi: 10.1073/pnas.91.7.2834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Schneider H., Cai Y. C., Cefai D., Raab M., Rudd C. E. Mechanisms of CD28 signalling. Res Immunol. 1995 Mar-Apr;146(3):149–154. doi: 10.1016/0923-2494(96)80248-3. [DOI] [PubMed] [Google Scholar]
  30. Schneider H., Cai Y. C., Prasad K. V., Shoelson S. E., Rudd C. E. T cell antigen CD28 binds to the GRB-2/SOS complex, regulators of p21ras. Eur J Immunol. 1995 Apr;25(4):1044–1050. doi: 10.1002/eji.1830250428. [DOI] [PubMed] [Google Scholar]
  31. Shahinian A., Pfeffer K., Lee K. P., Kündig T. M., Kishihara K., Wakeham A., Kawai K., Ohashi P. S., Thompson C. B., Mak T. W. Differential T cell costimulatory requirements in CD28-deficient mice. Science. 1993 Jul 30;261(5121):609–612. doi: 10.1126/science.7688139. [DOI] [PubMed] [Google Scholar]
  32. Shi Y., Radvanyi L. G., Sharma A., Shaw P., Green D. R., Miller R. G., Mills G. B. CD28-mediated signaling in vivo prevents activation-induced apoptosis in the thymus and alters peripheral lymphocyte homeostasis. J Immunol. 1995 Aug 15;155(4):1829–1837. [PubMed] [Google Scholar]
  33. Siliciano J. D., Morrow T. A., Desiderio S. V. itk, a T-cell-specific tyrosine kinase gene inducible by interleukin 2. Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11194–11198. doi: 10.1073/pnas.89.23.11194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Stein P. L., Lee H. M., Rich S., Soriano P. pp59fyn mutant mice display differential signaling in thymocytes and peripheral T cells. Cell. 1992 Sep 4;70(5):741–750. doi: 10.1016/0092-8674(92)90308-y. [DOI] [PubMed] [Google Scholar]
  35. Straus D. B., Weiss A. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell. 1992 Aug 21;70(4):585–593. doi: 10.1016/0092-8674(92)90428-f. [DOI] [PubMed] [Google Scholar]
  36. Tan P., Anasetti C., Hansen J. A., Melrose J., Brunvand M., Bradshaw J., Ledbetter J. A., Linsley P. S. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J Exp Med. 1993 Jan 1;177(1):165–173. doi: 10.1084/jem.177.1.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Tanaka N., Abe H., Yagita H., Okumura K., Nakamura M., Sugamura K. Itk, a T cell-specific tyrosine kinase, is required for CD2-mediated interleukin-2 promoter activation in the human T cell line Jurkat. Eur J Immunol. 1997 Apr;27(4):834–841. [PubMed] [Google Scholar]
  38. Tanaka N., Asao H., Ohtani K., Nakamura M., Sugamura K. A novel human tyrosine kinase gene inducible in T cells by interleukin 2. FEBS Lett. 1993 Jun 7;324(1):1–5. doi: 10.1016/0014-5793(93)81520-a. [DOI] [PubMed] [Google Scholar]
  39. Teng J. M., King P. D., Sadra A., Liu X., Han A., Selvakumar A., August A., Dupont B. Phosphorylation of each of the distal three tyrosines of the CD28 cytoplasmic tail is required for CD28-induced T cell IL-2 secretion. Tissue Antigens. 1996 Oct;48(4 Pt 1):255–264. doi: 10.1111/j.1399-0039.1996.tb02643.x. [DOI] [PubMed] [Google Scholar]
  40. Truitt K. E., Hicks C. M., Imboden J. B. Stimulation of CD28 triggers an association between CD28 and phosphatidylinositol 3-kinase in Jurkat T cells. J Exp Med. 1994 Mar 1;179(3):1071–1076. doi: 10.1084/jem.179.3.1071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Truitt K. E., Shi J., Gibson S., Segal L. G., Mills G. B., Imboden J. B. CD28 delivers costimulatory signals independently of its association with phosphatidylinositol 3-kinase. J Immunol. 1995 Nov 15;155(10):4702–4710. [PubMed] [Google Scholar]
  42. Vandenberghe P., Freeman G. J., Nadler L. M., Fletcher M. C., Kamoun M., Turka L. A., Ledbetter J. A., Thompson C. B., June C. H. Antibody and B7/BB1-mediated ligation of the CD28 receptor induces tyrosine phosphorylation in human T cells. J Exp Med. 1992 Apr 1;175(4):951–960. doi: 10.1084/jem.175.4.951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Ward S. G., Wilson A., Turner L., Westwick J., Sansom D. M. Inhibition of CD28-mediated T cell costimulation by the phosphoinositide 3-kinase inhibitor wortmannin. Eur J Immunol. 1995 Feb;25(2):526–532. doi: 10.1002/eji.1830250233. [DOI] [PubMed] [Google Scholar]
  44. Weiss A., Littman D. R. Signal transduction by lymphocyte antigen receptors. Cell. 1994 Jan 28;76(2):263–274. doi: 10.1016/0092-8674(94)90334-4. [DOI] [PubMed] [Google Scholar]
  45. Yamada N., Kawakami Y., Kimura H., Fukamachi H., Baier G., Altman A., Kato T., Inagaki Y., Kawakami T. Structure and expression of novel protein-tyrosine kinases, Emb and Emt, in hematopoietic cells. Biochem Biophys Res Commun. 1993 Apr 15;192(1):231–240. doi: 10.1006/bbrc.1993.1404. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES